Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06860880 · ClinicalTrials.gov registry record · NA

Combating Cancer-Related Fatigue: A Personalized Supportive Care Program

A NA study of Lymphoma and Chronic Lymphocytic Leukemia, sponsored by UNC Lineberger Comprehensive Cancer Center.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT06860880: Recruiting NA study of Lymphoma and Chronic Lymphocytic Leukemia, sponsored by UNC Lineberger Comprehensive Cancer Center.

NCT06860880 is a NA study of Lymphoma and Chronic Lymphocytic Leukemia that is actively recruiting participants, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 40 participants, below the 484-participant average among 299 other Lymphoma trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06860880, a NA study of Lymphoma and Chronic Lymphocytic Leukemia, is actively recruiting participants, sponsored by UNC Lineberger Comprehensive Cancer Center.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This health services study will assess a multidisciplinary intervention program directed at fatigue mitigation among patients diagnosed with indolent lymphomas. Specifically, 30 subjects with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and 10 subjects with Follicular Lymphoma (FL), marginal zone lymphoma (MZL), lymphoplasmacytic lymphoma (LPL), Waldenström's Macroglobulinemia, or Cutaneous T Cell Lymphoma (CTCL) will be included.

Primary Outcome

The proportion of consented patients with chronic lymphocytic leukemia (CLL) or other forms of indolent lymphoma who are referred to cancer rehabilitation and dietician and attend an initial appointment with each.

Conditions Studied

Lymphoma Chronic Lymphocytic Leukemia Follicular Lymphoma Small Lymphocytic Lymphoma Marginal Zone Lymphoma Waldenstrom Macroglobulinemia Cutaneous T Cell Lymphoma Lymphoplasmacytic Lymphoma Indolent Lymphomas

Interventions

  • OTHER Exercise
  • OTHER Diet

Study Locations (1)

North Carolina

  • North Carolina Basnight Cancer Hospital - Chapel Hill

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-06-03
Est. Completion 2026-12-31
Phase NA
UNC Lineberger Comprehensive Cancer Center

366 total trials

What NCT06860880 shows while recruiting

NCT06860880 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 484-participant average among 299 other Lymphoma trials with a reported enrollment target (92% lower).

The record links to 9 conditions, with Lymphoma appearing as the primary indexed condition, and to 2 interventions - of which Exercise is the first listed.

NCT06860880 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT06860880 about?

NCT06860880 is a clinical study titled "Combating Cancer-Related Fatigue: A Personalized Supportive Care Program". This health services study will assess a multidisciplinary intervention program directed at fatigue mitigation among patients diagnosed with indolent lymphomas. Specifically, 30 subjects with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and 10 subjects with Follicular Lymphoma (...

What is the current status of trial NCT06860880?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-06-03. Estimated completion is 2026-12-31.

What conditions does trial NCT06860880 study?

This clinical trial studies the following conditions: Lymphoma, Chronic Lymphocytic Leukemia, Follicular Lymphoma, Small Lymphocytic Lymphoma, Marginal Zone Lymphoma.

What interventions are being tested in trial NCT06860880?

The interventions under investigation include: Exercise (OTHER), Diet (OTHER).

Who is sponsoring clinical trial NCT06860880?

This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06860880 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Lymphoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06860880's enrollment target sits among peer trials

40 174th of 299 higher than 116 of 299 other Lymphoma trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Lymphoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

  • NCT02254863 · 40 participants · Phase 1

    UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06860880

Source: ClinicalTrials.gov NCT06860880, the US trial registry maintained by the National Library of Medicine. NCT06860880 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.